Will the U.S. Supreme Court be the Arbiter of Drug Safety? (Guest: Rik Mehta)

Download MP3
How is it that Mifepristone was approved in the first place?  The drug has high risk implications and because of that was authorized under a specific protocol that the Biden administration is now trying to change after the Dobb’s decision last year that reversed Roe v. Wade.  Guest Rik Mehta comes onto the podcast to discuss the legal nature of it all.

In The Tank broadcasts LIVE every Thursday at 12pm CT on on The Heartland Institute YouTube channel. Tune in to have your comments addressed live by the In The Tank Crew. Be sure to subscribe and never miss an episode. See you there!

Climate Change Roundtable is LIVE every Friday at 12pm CT on
The Heartland Institute YouTube channel. Have a topic you want addressed? Join the live show and leave a comment for our panelists and we'll cover it during the live show!

Creators and Guests

AnneMarie Schieber
Host
AnneMarie Schieber
AnneMarie Schieber brings decades of experience as an investigative news reporter to the forefront as host of Health Care News from The Heartland Institute. Along with hosting the podcast, Schieber is the managing editor of Health Care News, Heartland's monthly newspaper for health care reform. Before her work in the liberty movement, Schieber spent several decades at television stations in Michigan, Minnesota, New York and Pennsylvania. The Associated Press awarded her the top honor of "Best Individual Reporting" for being the first reporter to call attention to government efforts to subsidize spending by increasing automobile fines, typically on low-income motorists.
Will the U.S. Supreme Court be the Arbiter of Drug Safety? (Guest: Rik Mehta)